Repligen (RGEN) Tops Q2 EPS by 27c

Repligen (NASDAQ: RGEN) reported Q2 EPS of $0.79, $0.27 better than the analyst estimate of $0.52. Revenue for the quarter came in at $163 million versus the consensus estimate of $144.1 million.

GUIDANCE:

Repligen sees FY2021 revenue of $625-645 million, versus the consensus of $585.9 million.

For earnings history and earnings-related data on Repligen (RGEN) click here.

You May Also Be Interested In

• Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
• CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance
• Cheetah Net Supply Chain Service Inc. (CTNT) Reports Q2 EPS of $0.04